Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

GPC: combined diabetes QOF indicator 'will create cliff edge'

The GPC’s response to NICE’s recommendations for QOF in 2015/16 warns a composite diabetes indicator will ‘create a cliff edge’ in QOF payments and penalise practices with the most hard-to-reach patients. Read the statement in full

The combined diabetes indicator would create a cliff edge in payments and could put practices off doing any of the elements because of worries that a patient may not engage enough to complete the package. This is particularly true for opportunistic care which is often the only way hard-to-reach patients can be engaged.

It would be very unfair to practices that do a lot of work achieving all but one element of a diabetic programme only to lose all the funding because the patient did not attend for a cholesterol check or return a urine sample.

It also ignores that fact that many patients with diabetes have other long term conditions. Practices see many patients opportunistically and it is surely better to do some of the elements required by QOF during each consultation - every contact counts - which does risk the patient not returning for completion of the other elements.
  
Patients are human and do not all fit in to rigid guidelines and as adults can choose not to engage in treatment offered. It is also important not to overwhelm patients, and good medicine often involves discussion with the patient about what they feel is important and achievable, and concentrating on one thing at a time. The proposed approach might well cause overall care to be worse as patients give up and disengage.

There is also little value in measuring some of these indicators on an annual basis. In particular we believe the annual measurement of the following are unlikely to change management: ACR in patients known to have microalbumiuria or already on an ACE1 inhibitor; lipid measurement for patients already on treatment or who have declined or are unsuitable for drug treatment.

The overall effect of these changes will be to reduce the resource available for practices to deliver care to patients with diabetes, and the practices with the hardest-to-reach patients will be most affected.

Source: GPC’s response to NICE’s recommendations for QOF

 

Readers' comments (1)

  • This is the DoH agenda all along - make GPs do more for less. So what are you (GPC) going to actually DO about it?

    Unsuitable or offensive? Report this comment

Have your say